Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021

Christian Daniel Fankhauser,Jan Oldenburg,Peter Albers,Ferran Algaba, Carsten Bokemeyer,Joost L. Boormans,Stefanie Fischer,Karim Fizazi,Hendrik Gremmels,Javier Mayor de Castro,Florian Janisch,Tim Muilwijk,Ricardo Leão,David Nicol,Nicola Nicolai,Torgrim Tandstad,M. Pilar Laguna

European Urology（2021）

引用 6|浏览14

暂无评分

摘要

Men with metastatic germ cell tumors undergoing chemotherapy are at high risk of venous thromboembolic events and low risk of bleeding. A central venous-access device should be avoided whenever possible. Thromboprophylaxis may be prescribed after balancing the risks and benefits for each individual patient.

查看译文

关键词

Germ cell tumors,Testicular cancer,Chemotherapy,Intensive care medicine,Medicine,Position (obstetrics),First line chemotherapy,Risks and benefits,Venous access

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要